Michael Blaese

1.3k total citations
29 papers, 1.0k citations indexed

About

Michael Blaese is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Michael Blaese has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Michael Blaese's work include Virus-based gene therapy research (10 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (8 papers). Michael Blaese is often cited by papers focused on Virus-based gene therapy research (10 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (8 papers). Michael Blaese collaborates with scholars based in United States, France and Belgium. Michael Blaese's co-authors include Ian Magrath, Irma R. Koski, Nancy J. Dooley, Kleanthis G. Xanthopoulos, Ryuya Yamanaka, Ryuichi Tanaka, Robert A. Good, Carlos A. Martínez, Joost J. Oppenheim and Douglas J. Schwartzentruber and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Experimental Medicine.

In The Last Decade

Michael Blaese

28 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Blaese United States 20 460 322 308 290 153 29 1.0k
A. Amadori Italy 23 664 1.4× 454 1.4× 164 0.5× 323 1.1× 208 1.4× 62 1.6k
Josiane Ragimbeau France 15 746 1.6× 304 0.9× 124 0.4× 369 1.3× 137 0.9× 20 1.2k
William H. Schubach United States 21 244 0.5× 781 2.4× 220 0.7× 325 1.1× 156 1.0× 34 1.4k
James Skare United States 21 257 0.6× 567 1.8× 197 0.6× 437 1.5× 340 2.2× 41 1.3k
Torgny N. Fredrickson United States 18 587 1.3× 507 1.6× 211 0.7× 230 0.8× 255 1.7× 34 1.4k
Ian Mockridge United Kingdom 10 998 2.2× 537 1.7× 298 1.0× 308 1.1× 180 1.2× 12 1.6k
Christophe Demaison France 14 385 0.8× 404 1.3× 258 0.8× 131 0.5× 148 1.0× 24 956
Bonnie Mills United States 17 419 0.9× 359 1.1× 241 0.8× 378 1.3× 151 1.0× 41 1.0k
Ana Limón Spain 18 145 0.3× 704 2.2× 338 1.1× 292 1.0× 123 0.8× 28 1.1k
K L Cepek United States 11 1.2k 2.6× 437 1.4× 172 0.6× 197 0.7× 118 0.8× 12 1.9k

Countries citing papers authored by Michael Blaese

Since Specialization
Citations

This map shows the geographic impact of Michael Blaese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Blaese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Blaese more than expected).

Fields of papers citing papers by Michael Blaese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Blaese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Blaese. The network helps show where Michael Blaese may publish in the future.

Co-authorship network of co-authors of Michael Blaese

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Blaese. A scholar is included among the top collaborators of Michael Blaese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Blaese. Michael Blaese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamanaka, Ryuya, Naoki Yajima, Naoto Tsuchiya, et al.. (2002). Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus—mediated interleukin-12. Journal of neurosurgery. 97(3). 611–618. 40 indexed citations
2.
Yamanaka, Ryuya, Naoki Yajima, Naoto Tsuchiya, et al.. (2002). Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki Forest virus—mediated tumor complementary DNA. Journal of neurosurgery. 97(5). 1184–1190. 23 indexed citations
3.
Metz, Richard, et al.. (2002). Mode of Action of RNA/DNA Oligonucleotides. CHEST Journal. 121(3). 91S–97S. 20 indexed citations
4.
5.
Sharp, Harvey L., et al.. (2001). Primary Sclerosing Cholangitis in Wiskott–Aldrich Syndrome. Journal of Pediatric Gastroenterology and Nutrition. 32(1). 95–99. 2 indexed citations
6.
7.
8.
Leimig, Thasia, et al.. (1996). High-Efficiency Transduction of Freshly Isolated Human Tumor Cells Using Adenoviral Interleukin-2 Vectors. Human Gene Therapy. 7(10). 1233–1239. 26 indexed citations
9.
Blaese, Michael, T. Blankenstein, Malcolm K. Brenner, et al.. (1995). European school of Oncology position paper. Gene therapy for the medical oncologist. European Journal of Cancer. 31(9). 1531–1537. 4 indexed citations
10.
Rosenberg, Steven A., W. French Anderson, Michael Blaese, et al.. (1993). The Development of Gene Therapy for the Treatment of Cancer. Annals of Surgery. 218(4). 455–464. 53 indexed citations
11.
Rosenberg, Steven A., Anthony L. Asher, Michael Blaese, et al.. (1992). Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Tumor Necrosis Factor (National Institutes of Health). Human Gene Therapy. 3(1). 57–73. 38 indexed citations
12.
Rosenberg, Steven A., W. French Anderson, Michael Blaese, et al.. (1992). Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Interleukin-2 (National Institutes of Health). Human Gene Therapy. 3(1). 75–90. 33 indexed citations
13.
Kwan, Sau‐Ping, Thomas Lehner, Tracy L. Hagemann, et al.. (1991). Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22–Xp11.3. Genomics. 10(1). 29–33. 48 indexed citations
14.
Kwan, Sau‐Ping, L. A. Sandkuyl, Michael Blaese, et al.. (1988). Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers. Genomics. 3(1). 39–43. 45 indexed citations
15.
Gillio, Alfred P., Claudio Bordignon, Nancy A. Kernan, et al.. (1987). Retroviral Vector‐mediated Gene Transfer and Expression in Nonhuman Primates Following Autologous Bone Marrow Transplantationa. Annals of the New York Academy of Sciences. 511(1). 406–417. 1 indexed citations
16.
Briles, David E., Barry M. Gray, Marilyn J. Crain, et al.. (1987). Naturally Occurring Antibodies to Phosphocholine as a Potential Index of Antibody Responsiveness to Polysaccharides. The Journal of Infectious Diseases. 155(6). 1307–1314. 29 indexed citations
17.
Messina, Chiara, Dahlia Kirkpatrick, Patricia A. Fitzgerald, et al.. (1986). Natural killer cell function and interferon generation in patients with primary immunodeficiencies. Clinical Immunology and Immunopathology. 39(3). 394–404. 24 indexed citations
18.
Ilfeld, David, Martha K. Cathcart, Randall S. Krakauer, & Michael Blaese. (1981). Human splenic and peripheral blood lymphocyte response to lipopolysaccharide. Cellular Immunology. 57(2). 400–407. 9 indexed citations
19.
Martínez, Carlos A., Michael Blaese, & Robert A. Good. (1963). Male Skin Isograft Acceptance in Female Mice of the C57BL/1 Strain after Repeated Injections of Disrupted Spleen Cells. Nature. 198(4887). 1319–1321. 6 indexed citations
20.
Martínez, Carlos Alberto, Agustin P. Dalmasso, Michael Blaese, & R. A. Good. (1962). Runt Disease Produced in Thymectomized F1 Hybrid Mice Injected with Parental Strain Lymphoid Cells.. Experimental Biology and Medicine. 111(2). 404–407. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Amadori Breakdown of academic impact, for papers by Josiane Ragimbeau Breakdown of academic impact, for papers by William H. Schubach Breakdown of academic impact, for papers by James Skare Breakdown of academic impact, for papers by Torgny N. Fredrickson Breakdown of academic impact, for papers by Ian Mockridge Breakdown of academic impact, for papers by Christophe Demaison Breakdown of academic impact, for papers by Bonnie Mills Breakdown of academic impact, for papers by Ana Limón Breakdown of academic impact, for papers by K L Cepek
Rankless by CCL
2026